In8bio Inc (INAB) — Cash Flow-to-Debt Ratio
In8bio Inc (INAB) has a Cash Flow-to-Debt Ratio of -1.42x as of March 2026, meaning its operating cash flow of $-4.95 Million could theoretically repay -1% of its total liabilities ($3.48 Million) in one year. See working capital to net assets of In8bio Inc to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
In8bio Inc Cash Flow-to-Debt Ratio (2018–2025)
Historical debt coverage capacity for In8bio Inc across 8 annual periods. Also explore In8bio Inc equity growth rate to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for In8bio Inc (2018–2025)
Year-by-year debt coverage analysis for In8bio Inc. For market capitalisation and broader financial context, see In8bio Inc (INAB) total market value.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -2.69x | $-12.71 Million | $4.72 Million | ▲ +27.9% |
| 2024 | -3.73x | $-24.15 Million | $6.47 Million | ▼ -40.4% |
| 2023 | -2.66x | $-23.34 Million | $8.77 Million | ▼ -13.7% |
| 2022 | -2.34x | $-24.12 Million | $10.31 Million | ▲ +30.0% |
| 2021 | -3.34x | $-13.51 Million | $4.04 Million | ▼ -21.4% |
| 2020 | -2.76x | $-7.13 Million | $2.59 Million | ▲ +15.3% |
| 2019 | -3.25x | $-4.80 Million | $1.48 Million | ▼ -46.6% |
| 2018 | -2.22x | $-2.77 Million | $1.25 Million | — |